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Ameloblasts produce enamel matrix proteins such as amelogenin, ameloblastin, and amelotin during tooth development. The
molecular mechanisms of ameloblast diﬀerentiation (amelogenesis) are currently not well understood. SP6 is a transcription
factor of the Sp/KLF family that was recently found to regulate cell proliferation in a cell-type-speciﬁc manner. Sp6-deﬁcient mice
demonstrate characteristic tooth anomalies such as delayed eruption of the incisors and supernumerary teeth with disorganized
amelogenesis.However,itremainsunclearhowSp6 controlsamelogenesis.Inthisstudy,weusedSP6highproducercellstoidentify
SP6 target genes. Based on the observations that long-term culture of SP6 high producer cells reduced SP6 protein expression
but not Sp6 mRNA expression, we found that SP6 is short lived and speciﬁcally degraded through a proteasome pathway. We
established an in vitro inducible SP6 expression system coupled with siRNA knockdown and found a possible linkage between SP6
and amelogenesis through the regulation of amelotin and Rock1 gene expression by microarray analysis. Our ﬁndings suggest that
the regulation of SP6 protein stability is one of the crucial steps in amelogenesis.
1.Introduction
Speciﬁcity Protein 6 (Sp6), also known as epiproﬁn,i sa
member of the SP/KLF transcription factor family [1–3]. Sp6
mRNA is expressed in dental epithelial cells during tooth
development [3], and SP6 protein has been detected in the
ameloblast layer of rat incisors accompanied by amelogenin
expression [4]. The presence of two transcripts of Sp6 has
been reported due to alternative promoter usage with tissue-
and developmental stage-speciﬁc regulation, resulting in
connections of two diﬀerent ﬁrst exons (epiproﬁn e x o n1a n d
Sp6 exon 1) with the same second exon, which contains the
coding region [3,5].However,wehaverecentlyreportedthat
both transcripts are present in the same developmental stage
in dental epithelial cells, demonstrating that the Sp6 gene
comprises two ﬁrst exons (exon 1a and exon 1b) as well as
as e c o n de x o n[ 6].
Two other research groups have developed Sp6-deﬁcient
mice to explore the function of SP6 in vivo, and they
have reported several tooth abnormalities, including delayed
eruption of incisors, supernumerary teeth, and enamel
disorganization [7, 8]. We established a gain-of-function
system in vitro and found that SP6 inhibits follistatin (Fst)
gene expression in dental epithelial cells [4]. These ﬁndings
show that Sp6 is indispensable for tooth development.
However, the molecular basis for the biological functions of
SP6 remains unclear.
In this study, we found that SP6 is a short lived protein
that is speciﬁcally degraded via a proteasome pathway.
Based on these ﬁndings, we established an in vitro SP6
induction system using a proteasome inhibitor, MG132,
in combination with a small interfering RNA (siRNA)
knockdown technique. The system sharply distinguished the
presence or absence of SP6 protein in dental epithelial cells
with the same genetic background. Taking advantage of this
system, we screened SP6 target genes by DNA microarray
analysis. Identiﬁcation of amelotin (Amtn)a n dRock1 (Rho-
associated coiled-coil containing protein kinase 1) among the2 Journal of Biomedicine and Biotechnology
target genes suggested a speciﬁc role of SP6 in amelogenesis,
providing a molecular basis for the direct link between SP6
function and tooth development.
2.MaterialandMethods
2.1. Sp6 High Producer C9 Cells. SP6 high producer cells,
CHA9 cells, were previously established as a stable trans-
formant clone [4], originating from the rat dental epithelial
derived ameloblast-lineage clone, G5 [9]. G5 cells are a
c l o n e dc e l ld e r i v e df r o mar a te n a m e lo r g a n - d e r i v e dd e n t a l
epithelial sheet, expressed amelogenin mRNA, but not its
protein [9]. CHA9 cells were recloned by serial limiting
dilutions in the presence of G418 (400µg/mL: Nakalai
Tesque, Kyoto, Japan), and C9 cells, the clone with the
highest production of SP6, were selected by Western blot
analysis (WB). The cells were maintained in a combination
of Dulbecco’s modiﬁed Eagle’s medium/Ham’s F12 medium
(D/F12, Nissui, Tokyo, Japan) supplemented with 10% foetal
bovine serum (FBS, JRH Biosciences, Lenexa, Kan, USA).
2.2. Western Blot Analysis (WB). Protein lysates were ob-
tained by dissolving the cells in 2× sodium dodecyl sulfate
(SDS) sample buﬀer, as described previously [4]. Protein
concentration was measured using the BCA Protein Assay
Kit (Pierce, Rockford, Ill, USA). Thirty µg of total pro-
tein were loaded on 10% SDS-polyacrylamide gels (SDS-
PAGE). After electrophoresis, proteins were transferred to a
polyvinylidene diﬂuoride (PVDF) membrane (Immobilon;
Millipore, Bedford, Mass, USA) and blocked with 5% skim
milk in tris-buﬀered saline (TBS) (10mM Tris-HCl [pH
8.0], 150mM NaCl) with 0.05% Tween-20 for 3h at room
temperature (RT). The membranes were incubated with
anti-HA antibody (1:5000; Santa Cruz Biotechnology, Santa
Cruz, Calif, USA) overnight at 4◦C, and immunodetec-
tion was performed using the same procedure described
previously [4]. Quantiﬁcation analysis was performed by
densitometric scanning with “Quantity One” software (Bio-
Rad laboratories, Hercules, CA, USA) according to the
manufacturer’s instructions. Lysates of Cos7 cells transfected
with the CHA-Sp6 in pCIneo were used as a positive control
if not speciﬁed.
2.3. Reverse Transcription-PCR (RT-PCR) and Quantitative
PCR Analysis. Total RNA was puriﬁed using TRI Reagent
(Molecular Research Center. Inc., Cincinnati, Ohio, USA)
accordingtothemanufacturer’sinstructions.Aftertreatment
with DNase I (Invitrogen, Carlsbad, Calif, USA), 500ng
of total RNA were converted into cDNA using an RNA
PCR kit AMV Ver. 3.0 (Takara, Shiga, Japan) according
to the manufacturer’s instructions. Synthesized cDNA was
subjected to either PCR analysis using Taq DNA polymerase
(Promega, Madison, Wis, USA) or quantitative PCR (qPCR)
using Thunderbird SYBR qPCR Mix (Toyobo Co. Ltd.,
Osaka, Japan). Gene-speciﬁc primer sets are shown in
Table 1. qPCR was performed with a 7300 Real-Time PCR
System (Applied Biosystems, Carlsbad, Calif, USA). The
expression ratios were calculated from the threshold cycles
Table 1: Gene-speciﬁc primers.
Gene Primer sequence
Amelotin 5 -CCTCCTTATCCACCCCTTG-3 
5 -CCAACTGTGATGTGGTTTGC-3 
Car3 5 -CCTCTCTCTGGACCCTACC-3 
5 -TTTTGTCCAGGGCATCAAGG-3 
Follistatin 5 -TTTTCTGTCCACCGGCAGCTCCAC-3 
5 -GCAAGATCCGGAGTGCTTCACT-3 
Osr2 5 -ATTCACGAGAGGACCCACAC-3 
5 -GTTTCGCCTGAACACTTTGC-3 
Pcm1 5 -CTTGGGTGGCATCAAACTCC-3 
5 -CCAAGTGAATCACGGTGTTG-3 
Rock1 5 -GGATGCTACCTGATCACCAG-3 
5 -CCGTAGGCAAACCCGCAAG-3 
Sp6 cds 5 -CCGGCAATGCTAACCGCTGTCTGTG-3 
5 -GGCTCAGTTGGAGGACGCCGAGCTG-3 
Sp6
endogenous
5 -GCGCCATCTTCAGACCCAC-3 
5 -CCACTTCGCAAGAGGATTTC-3 
Sp6
exogenous
5 -GGCTAGAGTACTTAATACGACTCAC-3 
5 -CTCGAAGCATTAACCCTCACTAAAG-3 
18s rRNA 5 -TACCTGGTTGATCCTGCCAGTAGGAT-3 
5 -CCCGTCGGCATGTATTAGCTCTAGAA-3 
and normalized to 18s rRNA results. All data were conﬁrmed
by triplicate experiments.
2.4. SP6 Protein Stability and Half-Life. For lysosomal analy-
sis, C9 cells were treated with or without 1, 3, 10, and 20mM
of ammonium chloride (NH4Cl: Wako Pure Chemical
Industries, Ltd. Osaka, Japan) at 7 and 24h. For proteasomal
analysis, Cbz-leu-leu-leucinal (MG132: Calbiochem, EMD
Chemicals, Inc., San Diego, Calif, USA) or acetyl-leu-leu-
norleucinal (ALLN: Calbiochem, EMD Biosciences Inc.) was
applied to C9 cells. To investigate dose-dependent eﬀects, C9
cells were treated with 0.3 and 10µM of MG132 or 5, 10,
and 15µM of ALLN for 7 h. To analyze protein stability,
cycloheximide (CHX; Wako Pure Chemical Industries, Ltd.
Osaka, Japan) was used as described previously [10]. In
brief, C9 cells were preincubated with 10µM of MG132
for 8 h and washed with PBS(−) (137mM NaCl, 8.1mM
Na2HPO4·12H2O, 2.68mM KCl, 147mM KH2PO4, [pH
7.4]) twice. The medium was then replaced with fresh
medium, and 10mM CHX was added either alone or
together with MG132. The cells were harvested at the
indicated time points, and the cell lysates were used for WB.
2.5. 20S Proteasome Activity. A 20S proteasome activity
assay kit (Cayman Chemical Company, Ann Arbor, MI,
USA) was used to analyze proteasome activity in accordance
with the manufacturer’s protocol. In brief, G5 and C9
cells at passage 7 (P7) and P28 were prepared with or
without MG132 treatment for 8 h. Each cell preparation was
transferred into individual tubes with 1 × 105 cells. The
cells were then washed with 20S proteasome assay buﬀer.Journal of Biomedicine and Biotechnology 3
Table 2: Antibody information.
Antigen (clone) Company Code number Dilution (WB) Dilution (IC)
HA-tag (Y-11) Santa Cruz biotechnology sc-805 1:5000 1:250
HA-tag (3F10) Roche #867423001 1:1000 1:250
Ubiquitin DAKO Z0458 1:4500 —
Sumo1 (FL-101) Santa Cruz biotechnology sc-9060 1:1000 —
Sumo1 Cell signalling #4930 1:1000 —
Sumo2/3 (18H8) Cell signalling #4971 1:1000 —
(Santa Cruz biotechnology, Inc., Santa Cruz, Calif, USA; DAKO, Glostrup, Denmark; Cell signalling, Danvers, Mass, USA).
After centrifugation for 5min at 500g, the supernatant
was aspirated. One hundred µL of 20S Proteasome Lysis
buﬀer was added to the pellet and incubated at RT for
30min. After centrifugation for 10min at 1,000g, 90µLo f
the supernatant was transferred to a black 96-well detection
plate. After 10µLo fb u ﬀer or control inhibitor solution
was added to each well, 10µL of substrate (Suc-LLVY-
AMC) solution was added. The plate was then incubated
for 1h at 37◦C. The ﬂuorescent intensity of each well
(excitation at 360nm; emission at 480nm) was analysed
with Varioskan Flash (Thermo scientiﬁc, Waltham, Mass,
USA) and SkanIt Software (Thermo scientiﬁc) according
to the manufacturer’s instructions. All experiments were
performed in triplicate.
2.6. Immunocytochemistry (IC). C9 cells were seeded in a 12-
well plate. After treatment for 8 h with or without 10µM
MG132, the cells were washed with PBS(−)o n c e .T h ec e l l s
were then ﬁxed with 100% ethanol for 10min at RT. After
washing 3 times with PBS(−), the cells were permeabilized
with 0.2% Triton X-100 in PBS(−) for 15min at RT, then
blocked with 4% BSA in PBS(−)f o r3 0m i na tR T .T h e yw e r e
then incubated with HA-tagged antibody (1:250 dilution;
Santa Cruz Biotechnology) overnight at 4◦C. The next day,
the cells were washed with PBS(−) 3 times and incubated
with Alexa 594 anti-rabbit IgG (1:500 dilution; Molecular
Probes, Eugene, Ore, USA) and 1µg/mL Hoechst 33342 for
45min at RT. After washing the cells 3 times with PBS(−),
the wells were ﬁlled with PBS(−), and the plate was analysed
by ﬂuorescence microscopy (Table 2).
2.7. Knockdown of Sp6 by siRNA Transfection. Twenty-ﬁve
nM of Stealth RNAi siRNA for Sp6 (Sp6 siRNA; Invitrogen)
or Stealth RNAi siRNA Negative Control Duplex Med GC
#2 (GC; Invitrogen) was transfected into C9 cells at 30%
conﬂuency at P28 in a 12-well plate using Lipofectamine
RNAiMAX (MAX; Invitrogen) for 24 or 48h; the cells were
then harvested. TenµMo fM G 1 3 2w a sa d d e d8 hb e f o r e
harvesting the cells (i.e., the cells were subjected to 8h of
treatment with MG132).
2.8. Microarray Analysis. Total RNA was isolated from
Sp6 siRNA-MG132- or GC-MG132-treated C9 samples
using TRI Reagent. Purity was examined using an Agilent
2100 Bioanalyzer (Agilent Technologies, Santa Clara, Calif,
USA). Microarray analysis was performed using GeneChip
Rat Gene 1.0 ST Arrays (Aﬀymetrix, Santa Clara, Calif,
USA).Thismicroarraychipcontains27,342oligonucleotides
probes for known and unknown genes. First-strand cDNA
was synthesized from 300ng of total RNA using a WT
Expression Kit (Aﬀymetrix) according to the manufacturer’s
instructions. Ten µg of cRNA was added to the second-cycle
cDNA reaction. cDNA was fragmented and end-labelled
with a GeneChip WT Terminal Labeling Kit (Aﬀymetrix).
Approximately 5.5 µg of fragmentedand labelled DNA target
was hybridized to the array for 17h at 45◦C in a GeneChip
Hybridization Oven 640 (Aﬀymetrix) in accordance with the
manufacturer’s recommendations. Hybridized arrays were
washed and stained on a GeneChip Fluidics Station 450 and
scanned with a GeneChip Scanner 3000 7G (Aﬀymetrix),
and a CEL ﬁle was generated for each array. The data
were analysed with GeneSpring GX11.0 (Silicon Genetics,
Redwood City, Calif, USA). Expressed genes that showed
ﬂuorescenceintensitygreaterthan100werefurtheranalysed.
Genes with more than a 2-fold diﬀerence between the
Sp6 siRNA-treated samples and negative controls were
selected.
2.9. Statistics. The immunoprecipitation, Western blot anal-
yses, 20S proteasome activity, and qRT-PCR data presented
are representative of three independent analyses conducted
under the same experimental conditions. Determination of
the half-life of the SP6 protein was conducted twice using
individual analyses under the same experimental conditions.
The data reported reﬂect the means ± S.D. of triplicate
samples from the representative experiments.Student’s t-test
was utilized for proteasome activity by Microsoft Exel for
Mac 2008 (Redmond, Wash, USA).
3. Results
3.1. SP6 Expression during Long-Term Culture. In a previous
study, we established Sp6 stable transformants, CHA9 cells
[4], using the dental epithelial clone, G5 cells [9]. However,
we found that the level of SP6 was reduced in CHA9
cells during long-term culture. To investigate the molecular
nature and function of SP6, we recloned a new SP6 high
producer clone from CHA9 cells, C9 cells. Unexpectedly,
by WB, we again found a signiﬁcant reduction in the SP6
expression level in C9 cells at P28 compared with strong
SP6 expression at P7 (Figure 1(a)). In contrast, as shown
in Figure 1(b), the level of Sp6 mRNA cds, which detects4 Journal of Biomedicine and Biotechnology
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Figure 1: Downregulation of SP6 in C9 cells during long-term
culture. (a) SP6 expression in C9 cells (P7 and P28) and in parent
G5 cells. SP6 protein levels were analysed by WB using anti-
HA antibody. Arrow: SP6; asterisk: nonspeciﬁc band and Posi:
positive control. (b) Sp6 mRNA expression in C9 cells (P7 and
P28) and G5 cells. Upper panel indicates schematic structure of the
Sp6 gene and expression plasmid together with primer positions.
Primers designed to detect three distinct types of Sp6 mRNA.
Arrows indicate each primer’s position and direction. Grey box:
untranslated region; striped box: HA-tag; cds: coding region of
Sp6; endo: endogenous Sp6; exo: exogenous Sp6. Middle panel
shows the representative result of RT-PCR analysis. Lower panel
shows densitometric analysis data of RT-PCR. Each Sp6 level was
normalized by 18S rRNA level, and the relative ratio was calculated
compared to that of G5 cells. The level of G5 cells was assigned as
one.
the coding regions derived from both endogenous and
exogenous Sp6 mRNA, was about 3.2-and 2.2-fold higher
at P7 and P28, respectively, compared to that of the parent
G5 cells. The polygonal epithelial cell-like morphology and
growth rate were kept in C9 cells at P7 and P28. Based on
these ﬁndings, we assumed that the stability of SP6 protein is
involved in the regulation of SP6 expression.
3.2. Analysis of SP6 Stability. To explore the cause of the
reduction of SP6 protein expression in C9 cells at P28, we
examined two major pathways of protein degradation in
the cells: the proteasome and lysosomal pathways [11, 12].
We ﬁrst tested whether the lysosomal inhibitor NH4Cl had
any eﬀect on the inhibition of SP6 protein degradation. As
shown in Figure 2(a), we could not detect any enhancement
or induction of SP6 expression by NH4Cl at P7 or P28;
rather we found an acceleration of its reduction due to cell
toxicity at higher concentrations. Next we examined the
eﬀects of a proteasome inhibitor, MG132, on SP6 protein
expression in C9 cells. In contrast to NH4Cl, C9 cells treated
with 0.3 and 10µM of MG132 for 7h showed remarkably
enhanced levels of SP6 protein expression at P7 and P28
in a dose-dependent manner (Figure 2(b), upper panel). C9
cells treated with another proteasome inhibitor, ALLN, also
showed dose-dependent enhanced SP6 protein expression,
although the optimal dose was diﬀerent between P7 and P28
(Figure 2(b), lower panel). We further examined the eﬀect
of time course of MG132 treatment on SP6 expression. SP6
protein expression was gradually increased from 2 to 12h
after the addition of 10µM MG132 to the culture, and more
than 85% of maximal enhancement was obtained by 8h
of treatment, followed by a peak up to 68-fold increase at
12h (Figure 2(c)). To prove the proteasome activity in dental
epithelial cells, we measured the 20S proteasome activity in
C9 cells at P7 and P28 as well as in the parent G5 cells. C9
at P28 and G5 cells had the similar levels of 20S proteasome
activity (n = 3, P>0.01). C9 at P28, proteasome activity
became 67% of P7 (n = 3, P<0.01). We also observed
that G5 cells have statistically higher activity compared to
that of Jurkat cells (n = 3, P<0.01), which are a positive
control with high 20S proteasome activity provided in a
kit (Figure 2(d)), indicating a possible role of proteasome
activity in dental epithelial function.
We next analysed the stability of SP6 protein in C9 cells
at P28 to determine whether SP6 is a short lived protein.
C9 cells were cultured with 10mM CHX in the presence
or absence of MG132 as described in the experimental
section. As shown in Figure 2(e), regardless of whether
MG132 was retained continuously or refreshed, MG132
treatment maintained a similar SP6 level. When we changed
the medium to wash out MG132, the level of SP6 was rapidly
reduced to 25% of that of the peak within 1h (Figure 2(e)).
The half-life of the SP6 protein (t1/2) was assessed to be
approximately 40min. These results demonstrated that the
SP6 protein is actually a short lived protein and is rapidly
degraded through a proteasome pathway in dental epithelial
cells.
3.3. In Vitro Regulation of SP6 Expression in Combination
with MG132 Treatment and siRNA Knockdown. Although
a proteasome inhibitor, MG132, could markedly induce
and stabilize SP6 protein levels in C9 cells, it was not
clear whether MG132-induced SP6 were able to function
as a transcription factor. To address this question, we ﬁrst
examined the localization of the SP6 protein in MG132-
treated C9 cells at P28 by immunocytochemical analysis.
As shown in Figure 3(a), distinct SP6 signals was detectedJournal of Biomedicine and Biotechnology 5
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Figure 2: Eﬀects of protease inhibitors on SP6 expression level in C9 cells. (a) Dose-dependent eﬀects of the lysosomal inhibitor, NH4Cl,
on SP6 expression in C9 cells. The SP6 expression level was evaluated by WB. Posi: positive control; N: no treatment. (b) Dose-dependent
eﬀects of MG132 on SP6 expression in C9 cells. Upper panel: the cells were treated with MG132 (M) or DMSO (D) as a control (vehicle
alone) for 7h. Lower panel: cells were treated with ALLN (A) or DMSO (D) for 7h. Posi: positive control; N: no treatment; arrow: SP6;
asterisk: nonspeciﬁc band. (c) Time course of the eﬀects of MG132 treatment on SP6 induction in C9 cells. C9 cells at P28 were treated with
10µM MG132 during the indicated time. Upper panel: SP6 expression analysed by WB; Posi: positive control. Lower panel: Relative levels of
signal intensity of WB. Each SP6 level was shown as the relative level compared with the signal detected at 12h (100%). (d) 20S proteasome
activity in G5 and C9 cells (P7 and P28). J: Jurkat cells (positive control). The brackets show the signiﬁcant diﬀerence demonstrated by
Student’s t-test (n = 3,
∗P < 0.01). (e) Half-life analysis of SP6 in C9 cells at P28 determined by blocking de novo protein synthesis. C9 cells
were pretreated with MG132 for 8h, and then 10µg/mL CHX was added during the indicated time. Upper panel: SP6 expression detected
by WB; Retained: no medium change (MG132 was retained) when CHX was added; Refreshed: new medium replaced the old medium,
and MG132 was newly added to the culture with CHX; Eliminated: the medium was replaced without MG132, only CHX was added; Posi:
positive control; N: untreated C9 cells. Upper panel: relative SP6 expression level ratios. Each signal level was normalized with that at time 0
(100%). Data were reproduced by two independent experiments.6 Journal of Biomedicine and Biotechnology
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Figure 3: Speciﬁcity of SP6 induction by MG132 treatment. (a)
Subcellular localization of SP6 in C9 cells treated with MG132.
SP6 localization was analysed by immunoﬂuorescence signals. Red
colour indicates SP6 detected by anti-HA antibody, blue colour
shows nuclei stained with Hoechst 33342. (a–d): low magniﬁcation;
(e–h): high magniﬁcation. Scale bar indicates 200µm. (b) Knock-
down of SP6 in MG132-treated C9 cells by siRNA. Posi: positive
control; N: no treatment; M: Lipofectamine RNAiMAX only; GC:
negative control siRNA; si: siRNA against Sp6. Upper panel: SP6
expression was detected by WB. Lower panel: relative SP6 levels
estimated by densitometric analysis of WB results.
mainly in the nuclei of MG132-treated C9 cells and were
detected hardly at all in untreated cells. Nuclear localization
of SP6 was the same as native SP6 observed in vivo [4]. Next,
to check whether MG132-induced SP6 could regulate the
geneexpression,weexaminedRT-PCRanalysisof Fst mRNA
sincewepreviouslydemonstratedthatitisspeciﬁcallydown-
regulated by SP6 (4). We conﬁrmed the downregulation of
Fst mRNA in MG132-treated C9 cells (data not shown),
indicating that MG132-induced SP6 protein can act as a
transcription factor. These ﬁndings prompted us to further
analyze the SP6 target genes using an MG132-mediated
SP6 induction system in C9 cells. This is great advantage
to analyze SP6 functions in one cell line, in other words,
with the same genetic background. Because when we simply
compared transformant C9 cells with parental G5 cells, we
cannot eliminate the inﬂuences upon gene expression due to
the genomic insertion of transgene into C9 cells compared to
parental G5 cells.
To establish the speciﬁed SP6 induction system, we ﬁrst
checked the feasibility of in vitro MG132-mediated SP6
induction combined with siRNA knockdown to eliminate
the dosage eﬀect of Sp6 gene. As shown in Figure 3(b),
SP6 expression was completely inhibited in C9 cells treated
with Sp6-speciﬁc siRNA for both 24h and 48h compared
with control siRNA (GC-) treated cells. In addition, we
observed that C9 cells treated with siRNA for 48h produced
approximately 25% of the SP6 protein level at 24h. Since the
SP6 protein level in GC-treated cells was comparable with
that in untreated cells (N) as well as that in the cells treated
with transfection reagent (M) at 48h, this reduction was not
causedbyreagenttoxicity.Theseresultsconﬁrmedthatthein
vitroMG132-mediatedSP6inductionsystemcombinedwith
siRNA was a reliable experimental procedure for detecting
transcriptional target genes.
3.4. Identiﬁcation of Sp6 Target Genes by Microarray Anal-
ysis. To ﬁnd out the tissue-speciﬁc function of SP6 as a
transcription factor in dental epithelial cells, we performed
microarray analysis using the in vitro MG132-mediated SP6
induction system to compare SP6 siRNA-treated samples
and the control siRNA (GC) samples shown in Figure 3(b)
at 24h and 48h. Among 27,342 probes on the array, 74
(known genes: 47; unknown genes: 27) and 310 genes
(known genes: 190; unknown genes: 120) were regulated
by SP6 presence or absence at 24h and 48h, respectively
(Figure 4(a)). Twenty-one genes were commonly regulated
among the 24 and 48h-treated samples, 17 of which are
known genes. Among these, we found several potential
amelogenesis-related genes, including Amtn [13], Rock1 [14]
and Car3 (carbonic anhydrase 3)[ 15] among all samples, Fst
[4] in the 24h group of samples, and Pcm1 (pericentriolar
material 1)[ 16]a n dOsr2 (Odd-skipped 2)[ 17] in the 48h
group of samples. As shown in the right panel of Figure 4(a),
the Amtn, Pcm1, and Rock1 genes were positively regulated,
and the Fst, Car3, and Osr2 genes were negatively regulated,
by the presence of SP6 protein. To validate the microarray
data, we further analysed mRNA levels of these genes in C9
cells by qPCR analysis. The relative mRNA levels from the
microarray and qPCR results correlated well (Figure 4(b)).
Both the Amtn and Pcm1 genes were increased 8-9-fold at
48h compared with 24h, while the level of Rock1 mRNA
was similar between the two time points. On the other hand,
the Fst, Car3, and Osr2 genes were all reduced to 20%–50%
of the original level at 48h compared with 24h. To further
conﬁrm the speciﬁcity of the relationship between SP6
protein expression and target gene response, we examined
Amtn and Rock1 mRNA expression in C9 cells at P7 and P28.
The expression of Amtn and Rock1 mRNAs was signiﬁcantly
downregulated at P28 to 4.5% and 30%, respectively, of that
at P7 (Figure 4(c)). These data clearly demonstrated that the
stabilizationoftheSP6proteinregulatestheexpressionofthe
target genes in dental epithelial cells.Journal of Biomedicine and Biotechnology 7
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Figure 4: Screening of Sp6 target genes by microarray. (a) Venn diagram showing a summary of microarray data; the number of genes
that was changed more than 2-fold between the SP6 producing sample (GC: negative control of siRNA) and the SP6 knockdown sample
(siRNA of SP6) is also indicated. Numbers with brackets are unknown genes and those without brackets are known genes. The right panel
indicates that the expression levels of tooth-related genes were normalized using a control (GC) based on microarray data. (b) Conﬁrmation
of microarray data by qPCR. The fold changes were calculated and compared to that of 24 h control (GC 24; 100%). GC: negative control
siRNA; si: siRNA against Sp6. All experiments were performed in triplicate. (c) The mRNA levels of the Amtn and Rock1 genes in C9 at P7
and P28. qPCR was performed with total RNA puriﬁed from C9 cells at P7 and P28 and normalized by the level of 18s rRNA. The levels of
Amtn and Rock1 mRNA expression at P7 are indicated as 100%.8 Journal of Biomedicine and Biotechnology
4. Discussion
Both loss- and gain-of-function studies have demonstrated
that Sp6 is indispensable during development of teeth, skin,
limbs, lungs, and so on. [4, 7, 8, 18]. However, little is known
about the molecular basis for the biological role of Sp6 [19].
In this study, we obtained two important ﬁndings relating to
SP6;oneisitsstabilityinnature,andtheotheristhepotential
target genes during tooth development.
The ﬁrst ﬁnding was that the SP6 protein level is ﬁnely
tuned by a ubiquitin-independent proteasome pathway in
dental epithelial cells. SP6 protein is a short lived molecule
(t1/2 = 40min, Figure 2(e)) similar to the immediate-early
gene product, c-Fos (t1/2 = 47min during G0/G1 transition
in Balb/C3T3 ﬁbroblasts) [20]. Many transcription factors
are short lived proteins and are degraded via a proteasome
pathway [11], indicating that transcription factors are tightly
regulated to maintain homeostasis at speciﬁc diﬀerentiation
stages or tissue circumstances. Notably, the level of Sp6
mRNA was maintained at a similar level during long-term
culture, although SP6 protein expression was transiently
high during early cell passage and was maintained at a
low level during later passages (Figures 1(a) and 1(b)). 20S
proteasome activities in dental epithelial cells are constantly
high (Figure 2(d)); however, the underlying mechanisms
of transient SP6 expression during early passage remain
unclear.
In general, proteasome degradation is mediated by
ubiquitin-dependent or -independent pathways [21]. The
ubiquitin-dependent pathway is known to be initiated by
polyubiquitination or other posttranslational modiﬁcations,
such as sumoylation and phosphorylation of the target
proteins[22].Wefoundpossiblesitesforthesemodiﬁcations
in the rat SP6 sequence; however, we could not detect any
modiﬁcations of SP6 (data not shown). It is quite interesting
issue to see how SP6 was stabilized in C9 cells at P7 but
not in C9 cells at P28 or in the parent G5 cells in relation
to proteasome regulation. A unique structural feature of
the SP6 protein among the Sp/KLF family is a proline-
rich sequence at the N-terminal half of the SP6 protein
[1, 2]. Since proline-rich sequences often form a protein-
protein binding interface [23], the binding partner(s) of
SP6 via this region could be involved in SP6 stability.
Further investigations are required for better understanding
of proteasome regulation of SP6 stability and its relationship
to SP6 protein binding partners.
The second important ﬁnding was the identiﬁcation
of novel SP6 target genes linked with amelogenesis. We
ﬁrst developed an in vitro MG132-mediated SP6 induc-
tion system combined with siRNA knockdown technology
(Figure 3). The most important feature of this in vitro system
isthatitenablesdirectinvestigationofthedownstreamtarget
genes during SP6 functioning maintaining the same genetic
background. Taking advantage of this system, we screened
and identiﬁed potential target genes by microarray analysis.
We found 6 tooth-related genes, Amtn, Pcm1, Rock1, Fst,
Car3, and Osr2, which were regulated by the SP6 protein
(Figure 4).
Amtn/ Rock1
Factor X
BMP
Wnt
BRE WRE
Amelogenesis
Proteasome GC box
SP6
Sp6
Figure 5: Proposed model of Sp6 expression and function coupled
with amelogenesis in dental epithelial cells. BMP and Wnt signals
can enhance Sp6 promoter activity, resulting in the enhancement
of Sp6 mRNA expression (6). The level of SP6 protein expression
is regulated by proteasome activity, which would be physiologically
controlledbyaMG132-equivalentfactorX.StabilizedSP6proteinis
transferredintothenucleusandregulatestheexpressionofamelotin
and rock1 mRNA. BRE: BMP signal-responsive elements; WRE:
Wnt signal-responsive elements.
Among these, the Amtn gene was strikingly upregulated
by the presence of SP6 protein. The Amtn gene was recently
described as a novel ameloblast-speciﬁc gene [13, 24, 25],
and it is highly conserved in mammals; the rat Amtn gene
is located at chromosome 14p21 where it is quite close to
other ameloblast-speciﬁc genes, including ameloblastin and
enamelin at chromosome 14p22 [24, 25]. In addition, the
AMTN protein has been detected in the enamel matrix at the
postsecretory transition and maturation stage of ameloblasts
during enamel development [13, 24, 26], since SP6 protein
is expressed in the ameloblast layer from the presecretory
stage to the secretory stage in the enamel-forming region
[4], indicating a sequential expression pattern of SP6 and
AMTN. Another SP6 target gene in amelogenesis is Rock1,
a notable gene in amelogenesis. ROCK1 protein expression
is localized in the inner enamel epithelium in presecretory
throughmatureameloblastsandthestratumintermediumin
dental epithelial cells, regulating cell morphology, adhesion
t oc o n t r o lc e l lp r o l i f e r a t i o na n dc e l lp o l a r i t y[ 14, 27].
Altogether, SP6 functions, at least in part, through Amtn
or Rock1 regulation in amelogenesis. To the best of our
knowledge, this is the ﬁrst report to demonstrate a molecular
connection between SP6 function and the late stage of
amelogenesis related genes. In Figure 5, we summarize our
current model of SP6 expression and its functional coupling
with amelogenesis, incorporating our present study with
previous observations [6, 18].
In conclusions, we found that SP6 protein is short
lived, and our in vitro SP6 induction system coupled
with microarray analysis identiﬁed novel ameloblast-speciﬁc
target genes. Our ﬁndings provide the molecular basis forJournal of Biomedicine and Biotechnology 9
the nature of the SP6 protein and its possible function as a
transcription factor in dental epithelial cells. Further studies
are required to analyze the tight regulation of both SP6
protein expression and stability during tooth development
to clarify the biological roles of SP6. Specially we have to
conﬁrm direct binding of SP6 to the new target genes in this
system and endogenous system in vitro. Furthermore, to link
with in vivo function in amelogenesis, we need to establish
ameloblast diﬀerentiation system to mimic in vivo status,
for example, 3D culture or organ culture combined with
siRNA technology and observe the diﬀerentiation markers.
These issues may provide further hints in relation to the
developmental regulatory system and cellular physiological
homeostasis.
Acknowledgments
The authors would like to extend their special thanks to Mr.
Hideaki Horikawa, Support Center for Advanced Medical
Sciences, the University of Tokushima Graduate School,
Institute of Health Biosciences, for his support with the
microarray analyses. This work was partly supported by
Grants-in-aid for Scientiﬁc Research (no. 21791805) and
Cooperative Research Grant of the Institute for Enzyme
Research, the University of Tokushima, as well as a Research
Grant from KAO Health Science Research.
References
[1] G. Suske, E. Bruford, and S. Philipsen, “Mammalian SP/KLF
transcription factors: bring in the family,” Genomics, vol. 85,
no. 5, pp. 551–556, 2005.
[2] S. Scohy, P. Gabant, T. van Reeth et al., “Identiﬁcation of
KLF13 and KLF14 (Sp6), novel members of the Sp6/XKLF
transcription factor family,” Genomics, vol. 70, pp. 93–101,
2000.
[3] T. Nakamura, F. Unda, S. de-Vega et al., “The Kruppel-like
factorepiproﬁnisexpressedbyepitheliumofdevelopingteeth,
hair follicles, and limb buds and promotes cell proliferation,”
Journal of Biological Chemistry, vol. 279, no. 1, pp. 626–634,
2004.
[4] I. Ruspita, K. Miyoshi, T. Muto, K. Abe, T. Horiguchi, and T.
Noma, “Sp6 down regulation of follistatin gene expression in
ameloblast,” Journal of Medical Investigation, vol. 55, no. 1-2,
pp. 87–98, 2008.
[5] V. Hertveldt, C. De Mees, S. Scohy, P. Van Vooren, J. Szpirer,
and C. Szpirer, “The Sp6 locus uses several promoters and
generate sense and antisense transcripts,” Biochimie, vol. 89,
no. 11, pp. 1381–1387, 2007.
[6] I. A. Wahyudi, T. Horiguchi, K. Miyoshi et al., “Isolation
and characterization of mouse speciﬁcity 6 promoter,” The
Indonesian Journal of Dental Research, vol. 1, pp. 21–34, 2010.
[7] T. Nakamura, S. De Vega, S. Fukumoto, L. Jimenez, F. Unda,
and Y. Yamada, “Transcription factor epiproﬁn is essential
for tooth morphogenesis by regulating epithelial cell fate and
tooth number,” Journal of Biological Chemistry, vol. 283, no. 8,
pp. 4825–4833, 2008.
[8] V. Hertveldt, S. Louryan, T. Van Reeth et al., “The develop-
ment of several organs and appendages is impaired in mice
lacking Sp6,” Developmental Dynamics, vol. 237, no. 4, pp.
883–892, 2008.
[9] K. Abe, K. Miyoshi, T. Muto et al., “Establishment and
characterization of rat dental epithelial derived ameloblast-
lineage clones,” Journal of Bioscience and Bioengineering, vol.
103, no. 5, pp. 479–485, 2007.
[ 1 0 ]V .A z z u ,S .A .M o o k e r j e e ,a n dM .D .B r a n d ,“ R a p i dt u r n o v e r
of mitochondrial uncoupling protein 3,” Biochemical Journal,
vol. 426, no. 1, pp. 13–17, 2010.
[11] D. H. Lee, “Proteasome inhibitors: valuable new tools for cell
biologists,” Trends in Cell Biology, vol. 8, no. 10, pp. 397–403,
1998.
[12] H. Schulze, T. Kolter, and K. Sandhoﬀ, “Principles of lysoso-
mal membrane degradation cellular topology and biochem-
istry of lysosomal lipid generation,” Biochimica et Biophysica
Acta, vol. 1793, no. 4, pp. 674–683, 2009.
[13] P. Moﬀatt, C. E. Smith, R. St.-Arnaud R., D. Simmons,
J. T. Wright, and A. Nanci, “Cloning of rat amelotin and
localization of the protein to the basal lamina of maturation
stage ameloblasts and junctional epithelium,” Biochemical
Journal, vol. 399, no. 1, pp. 37–46, 2006.
[14] K.Otsu,R.Kishigami,N.Fujiwara,K.Ishizeki,andH.Harada,
“Functional role of Rho-kinase in ameloblast diﬀerentiation,”
Journal of Cellular Physiology, vol. 226, no. 10, pp. 2527–2534,
2011.
[15] R. S. Lacruz, M. Hilvo, I. Kurtz, and M. L. Paine, “A survey
of carbonic anhydrase mRNA expression in enamel cells,”
Biochemical and Biophysical Research Communications, vol.
393, no. 4, pp. 883–887, 2010.
[16] R. Balczon, C. Simerly, D. Takahashi, and G. Schatten,
“Arrest of cell cycle progression during ﬁrst interphase in
murine zygotes microinjected with anti-PCM-1 antibodies,”
Cell Motility and the Cytoskeleton, vol. 52, no. 3, pp. 183–192,
2002.
[17] Z. Zhang, Y. Lan, Y. Chai, and R. Jiang, “Antagonistic actions
of Msx1 and Osr2 pattern mammalian teeth into a single row,”
Science, vol. 323, no. 5918, pp. 1232–1234, 2009.
[18] A.Talamillo,I.Delgado,T.Nakamuraetal.,“Roleofepiproﬁn,
a zinc-ﬁnger transcription factor, in limb development,”
Developmental Biology, vol. 337, no. 2, pp. 363–374, 2010.
[19] L. Jimenez-Rojo, G. Ibarretxe, M. Aurrekoetxea et al.,
“Epiproﬁn/Sp6: a new player in the regulation of tooth
development,”HistologyandHistopathology,vol.25,pp.1621–
1630, 2010.
[20] P. Ferrara, E. Andermarcher, G. Bossis et al., “The struc-
tural determinants responsible for c-Fos protein proteasomal
degradation diﬀer according to the conditions of expression,”
Oncogene, vol. 22, no. 10, pp. 1461–1474, 2003.
[21] A. V. Sorokin, E. R. Kim, and L. P. Ovchinnikov, “Proteasome
system of protein degradation and processing,” Biochemistry
(Moscow), vol. 74, no. 13, pp. 1411–1442, 2009.
[22] M. C. Geoﬀroy and R. T. Hay, “An additional role for SUMO
in ubiquitin-mediated proteolysis,” Nature Reviews Molecular
Cell Biology, vol. 10, no. 8, pp. 564–568, 2009.
[23] R. Ren, B. J. Mayer, P. Cicchetti, and D. Baltimore, “Identi-
ﬁcation of a ten-amino acid proline-rich SH3 binding site,”
Science, vol. 259, no. 5098, pp. 1157–1161, 1993.
[24] K. Iwasaki, E. Bajenova, E. Somogyi-Ganss et al., “Amelotin—
a novel secreted, ameloblast-speciﬁc protein,” Journal of
Dental Research, vol. 84, no. 12, pp. 1127–1132, 2005.
[25] P. Moﬀatt, C. E. Smith, R. Sooknanan, R. St-Arnaud, and
A. Nanci, “Identiﬁcation of secreted and membrane proteins
in the rat incisor enamel organ using a signal-trap screening
approach,” European Journal of Oral Sciences, vol. 114, no. 1,
pp. 139–146, 2006.10 Journal of Biomedicine and Biotechnology
[ 2 6 ]R .J .R a u t h ,K .S .P o t t e r ,A .Y .N g a ne ta l . ,“ D e n t a le n a m e l :
genes deﬁne biomechanics,” Journal of the California Dental
Association, vol. 37, no. 12, pp. 863–868, 2009.
[27] M. T. Biz, M. R. Marques, V. O. Crema, A. S. Moriscot, and
M. F. Dos Santos, “GTPases RhoA and Rac1 are important
for amelogenin and DSPP expression during diﬀerentiation of
ameloblast and odontoblas,” Cell and Tissue Research, vol. 340,
no. 3, pp. 459–470, 2010.